cyprotex
the ADME Tox specialists
welcome to cyprotex

Investor News

May 22, 2003 - Closure of Spread Bet

Cyprotex PLC ("the Company") has received today a letter from City Index Limited confirming that all spread bets placed by Paul Davidson with City Index Limited in relation to Cyprotex plc have been unconditionally closed.

For further information:

Dr David Leahy, Joint Chief Executive Officer, Chief Scientific Officer
John Nicholson, Joint Chief Executive Officer, Chief Operating Officer
Cyprotex PLC
Tel: +44 (0) 1625 505 100
j.nicholson@cyprotex.com
d.leahy@cyprotex.com
www.cyprotex.com

Phil Adams
Altium Capital

Tel: +44(0) 161 831 1203

Media enquiries:

Heather Salmond / Julian Bosdet (for Cyprotex)
Bankside Consultants Limited

Tel: +44 (0) 20 7444 4140
www.bankside.com

Ken Cronin / Neil Bennett (for City Index)
Gavin Anderson

Tel: +44 (0)20 7554 1400

view all the latest news +
2013 archive +
2012 archive +
2011 archive +
2010 archive +
2009 archive +
2008 archive +
2007 archive +
2006 archive +
2005 archive +
2004 archive +
2003 archive +
2002 archive +
contact

Find out more about us.

Investor Relations
Anthony Baxter/Mark Warburton

Call on +44 1625 505100

contact
careerscontactlegalprivacy
This website was last updated
on 16th April 2014
This website is intended to assist investors, industry participants, customers and employees to understand Cyprotex’s global operations and ambitions.
Certain information and detail is disclosed in the interest of compliance of AIM Rule 26.